EP Patent

EP0270316A3 — Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne

Assigned to Pfizer Inc · Expires 1989-12-06 · 36y expired

What this patent protects

Topical acne compositions comprising from 1-10% w/w of a lipophilic 1-substituted imidazole antimicrobial agent and from 1-25% w/w of a non-steroidal antiinflammatory agent.

USPTO Abstract

Topical acne compositions comprising from 1-10% w/w of a lipophilic 1-substituted imidazole antimicrobial agent and from 1-25% w/w of a non-steroidal antiinflammatory agent.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0270316A3
Jurisdiction: EP
Classification: —
Expires: 1989-12-06
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.